RingelMD, SosaJA, BalochZ, et al.2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer. Thyroid2025;35(8):841-985; doi: 10.1177/10507256251363120.
2.
FujiwaraT, KofujiN, KishimotoY, et al.Are total thyroidectomy and adjuvant radioactive iodine treatment required in all patients with N1b intermediate-high risk papillary thyroid carcinoma? Thyroid2026;36(1):36-45; doi: 10.1177/10507256251401241.
3.
AbelleiraE, JerkovichF. Dynamic risk assessment in patients with differentiated thyroid cancer. Rev Endocr Metab Disord2024;25(1):79-93; doi: 10.1007/s11154-023-09857-7.
4.
WeisH, WeindlerJ, SchmidtK, HellmichM, DrzezgaA, SchmidtM. Impact of radioactive iodine treatment on long-term relative survival in patients with papillary and follicular thyroid cancer: A SEER-based study covering histologic subtypes and recurrence risk categories. J Nucl Med2025;66(4):525-530; doi: 10.2967/jnumed.124.269091.
5.
CuéllarDI, De Los ReyesA, Llamas-OlierA. Modified dynamic risk stratification system further predicts individual outcome in patients with intermediate-risk papillary thyroid cancer. Ann Endocrinol (Paris)2023;84(2):242-248; doi: 10.1016/j.ando.2022.03.003.
6.
KlainM, NappiC, ZampellaE, et al.Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: A systematic review and a meta-analysis. Eur J Nucl Med Mol Imaging2021;48(13):4437-4444; doi: 10.1007/s00259-021-05440-x.
7.
MomessoDP, VaismanF, YangSP, et al.Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine. J Clin Endocrinol Metab2016;101(7):2692-2700; doi: 10.1210/jc.2015-4290.
8.
ChoJW, LeeYM, LeeYH, HongSJ, YoonJH. Dynamic risk stratification system in post-lobectomy low-risk and intermediate-risk papillary thyroid carcinoma patients. Clin Endocrinol (Oxf)2018;89(1):100-109; doi: 10.1111/cen.13721.
9.
ParkJH, MoonGS, NamKT, YoonJH. Optimal timing of initiating dynamic risk stratification during the early postoperative period in patients with differentiated thyroid carcinoma after thyroidectomy and radioactive iodine remnant ablation. Ann Surg Oncol2021;28(11):6580-6589; doi: 10.1245/s10434-021-09721-5.
10.
KimBH, RyuSR, LeeJW, et al.Longitudinal changes in quality of life before and after thyroidectomy in patients with differentiated thyroid cancer. J Clin Endocrinol Metab2024;109(6):1505-1516; doi: 10.1210/clinem/dgad748.
